Literature DB >> 31367921

Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice.

Shaheen Jafri Ali1, Govindraj Ellur1,2, Kalpana Patel1,2, Kunal Sharan3,4.   

Abstract

Prenatal and early life exposure of chlorpyrifos (CPF), a widely used pesticide, is known to cause neuronal deficits and Parkinson's disease (PD). However, data about the effect of its exposure at adult stages on PD-like symptoms and associated bone loss is scanty. In the present study, we investigated the impact of CPF on the behavioral alterations seen in PD using adult Swiss albino mice. PD is often associated with bone loss. Hence, skeletal changes were also evaluated using micro-computed tomography and histology. MPTP was used as a positive control. Cell culture studies using MC3T3E-1, SHSY5Y, and primary osteoclast cultures were done to understand the cellular mechanism for the behavioral and skeletal changes. Our results showed that CPF treatment leads to PD-like symptoms due to the loss of dopaminergic neurons. Moreover, CPF has a deleterious effect on the trabecular bone through both indirect changes in circulating factors and direct stimulation of multinucleate osteoclast cell formation. The impact on the bone mass was even stronger than MPTP. In conclusion, this is the first report demonstrating that CPF induces parkinsonian features in adult Swiss albino mice and it is accompanied by loss of trabecular bone.

Entities:  

Keywords:  Chlorpyrifos; Dopamine; Osteoclast; Osteoporosis; Parkinson’s disease

Mesh:

Substances:

Year:  2019        PMID: 31367921     DOI: 10.1007/s12640-019-00092-0

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  52 in total

Review 1.  Risk assessment under FQPA: case study with chlorpyrifos.

Authors:  C B Clevelan; G R Oliver; B Chen; J Mattsson
Journal:  Neurotoxicology       Date:  2001-10       Impact factor: 4.294

2.  Protocol for the MPTP mouse model of Parkinson's disease.

Authors:  Vernice Jackson-Lewis; Serge Przedborski
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 3.  [Frontiers in Live Bone Imaging Researches. Functional cross talk between bone and nervous system].

Authors:  Toru Fukuda; Shu Takeda
Journal:  Clin Calcium       Date:  2015-06

4.  Postnatal chlorpyrifos exposure and apolipoprotein E (APOE) genotype differentially affect cholinergic expression and developmental parameters in transgenic mice.

Authors:  Pia Basaure; Laia Guardia-Escote; Maria Cabré; Fiona Peris-Sampedro; Fernando Sánchez-Santed; José L Domingo; Maria Teresa Colomina
Journal:  Food Chem Toxicol       Date:  2018-05-03       Impact factor: 6.023

Review 5.  Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.

Authors:  David L Eaton; Robert B Daroff; Herman Autrup; James Bridges; Patricia Buffler; Lucio G Costa; Joseph Coyle; Guy McKhann; William C Mobley; Lynn Nadel; Diether Neubert; Rolf Schulte-Hermann; Peter S Spencer
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

6.  Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease.

Authors:  Shaheen Jafri Ali; Padmanabhan Sharda Rajini
Journal:  Toxicol Ind Health       Date:  2014-09-16       Impact factor: 2.273

Review 7.  Risk and Prevention of Fracture in Patients With Major Medical Illnesses: A Mini-Review.

Authors:  Steven R Cummings; Richard Eastell
Journal:  J Bone Miner Res       Date:  2016-12       Impact factor: 6.741

8.  Effects of maternal chlorpyrifos diet on social investigation and brain neuroendocrine markers in the offspring - a mouse study.

Authors:  Aldina Venerosi; Sabrina Tait; Laura Stecca; Flavia Chiarotti; Alessia De Felice; Maria Francesca Cometa; Maria Teresa Volpe; Gemma Calamandrei; Laura Ricceri
Journal:  Environ Health       Date:  2015-04-02       Impact factor: 5.984

9.  Risk of fracture amongst patients with Parkinson's disease and other forms of parkinsonism.

Authors:  Isobel Sleeman; Zhu Chung Che; Carl Counsell
Journal:  Parkinsonism Relat Disord       Date:  2016-05-26       Impact factor: 4.891

10.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

View more
  2 in total

Review 1.  Preventing Parkinson's Disease: An Environmental Agenda.

Authors:  Briana R De Miranda; Samuel M Goldman; Gary W Miller; J Timothy Greenamyre; E Ray Dorsey
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

2.  Caenorhabditis elegans Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework.

Authors:  Shreesh Raj Sammi; Laura E Jameson; Kendra D Conrow; Maxwell C K Leung; Jason R Cannon
Journal:  Front Toxicol       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.